Voisin Consulting Life Sciences is a team of 150 life sciences professionals, committed to delivering innovative therapies to patients. We believe that product development must be driven by a solid understanding of the environment within which the product will be launched, and the criteria by which elements of the development will be assessed by both regulators and payers. We start from science and medical needs, as we collaborate with our clients’ teams to drive innovative products along development and commercialization.
Dr. Emmanuelle M. Voisin founded Voisin Consulting Life Sciences in 1997 to offer product development services tailored to the very specific needs of small Biotech companies. Over the years, Emmanuelle has assembled a team of seasoned industry professionals of complementary expertise, to offer combined strategic and operational capabilities addressing the needs of health products developers. Today, our team is also consulted by top-10 Biotech, Pharma, Medtech, Food, and Cosmetic manufacturers.
Regulatory Resources Group (RRG) joined VCLS group in 2013. The combined operation consolidates VCLS service range notably in regulatory science, interim management and training services. RRG employees are now working with VCLS’ team to strengthen the group’s capabilities in helping clients drive their products to the international marketplace. Located in Camberley (UK), the award-winning Regulatory Resources Group is one of the longest-established independent regulatory consultancies in Europe. This acquisition is part of VCLS’ global growth strategy.
B&H Consulting Services, Inc. (B&H) joined the VCLS group in 2015. The acquisition forms one of the largest independent consulting groups delivering high-end regulatory services to support the interactions with the U.S. Food and Drug Administration, the European Medicines Agency, and other global health authorities. Based in Somerville, NJ, B&H Consulting Services reinforces VCLS’ capabilities with in-depth Chemistry, Manufacturing and Controls expertise, as well as strategic and operational support for all regulatory submissions including electronic publishing services.